Chen et al. reported that silencing PDIA5 in human glioma cells upregulates PD-L1 expression, suggesting that PDIA5, by modifying disulfide bonds and activating the UPR, may influence PD-L1 expression, although the exact mechanisms involved are unexplored [109]. The gene discussed is PDIA5; the disease is central nervous system cancer.